Seeking Novel Drug Candidates and Targets for Progressive Fibrosing Interstitial Lung Diseases and Acute Respiratory Distress Syndrome

CSL is interested in respiratory therapeutics in the areas of Interstitial Lung Diseases (ILD) and Acute Respiratory Distress Syndrome (ARDS).

For ILD‑related research, halting and reversing fibrosis is a key element of interest. For ARDS‑related research, a focus on Community Acquired Pneumonia (CAP) is of key importance.

Approaches of Particular Interest

• Biologics and Antibody Therapeutics will be prioritized
• Cell and Gene Therapies

Developmental Stage

Validation with patient data, biomarkers, and/or in animal models preferable. Ex vivo models (e.g....